查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1931196

複合疝氣修補片市場按材料類型、方法、最終用戶和應用分類－全球預測，2026-2032年

Composite Hernia Patch Market by Material Type, Approach, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，複合疝氣修補片市場價值將達到 11.4 億美元，到 2026 年將成長至 11.9 億美元，到 2032 年將達到 17.2 億美元，年複合成長率為 6.11%。

關鍵市場統計數據
基準年 2025 11.4億美元
預計年份：2026年 11.9億美元
預測年份 2032 17.2億美元
複合年成長率 (%) 6.11%

本文概述了複合疝氣修補片的臨床原理、監管趨勢以及影響其應用路徑和產品開發的相關人員優先事項。

複合疝氣修補片已成為現代疝氣修補術中不可或缺的工具，它結合了基質和屏障技術，旨在平衡組織完整性和降低粘連風險。本文概述了其臨床原理、核心產品特性以及相關人員的考量，這些因素共同決定了當前的應用趨勢，並為更深入的分析奠定了基礎。臨床醫生主要根據生物相容性、操作特性、固定要求和長期患者療效來評估複合結構，這些結構影響採購和產品開發決策。

手術技術偏好、材料創新和採購壓力的重大變化正在重新定義產品設計和應用趨勢。

近年來，複合疝氣修補片的研發、應用和報銷方式發生了許多變化，了解這些變化對於策略規劃至關重要。首先，微創和日間手術流程的興起，使得針對腹腔鏡操作性、快速部署和牢固固定而最佳化的網片變得尤為重要，進而影響了產品設計選擇和培訓投入。因此，製造商優先考慮低輪廓結構和輸送系統，以縮短手術時間並簡化無需縫合和釘合的固定方式。

關稅主導的供應鏈重組、採購多元化和採購審查力度增加對成本管理和商業性合作的影響（2025年）

2025年美國關稅政策對複合疝氣修補片相關人員的供應鏈、籌資策略和價格最佳化工作產生了重大影響。為了應對關稅帶來的成本壓力，製造商和經銷商重新評估了其採購策略，優先考慮近岸外包和供應商多元化，以降低對單一供應商的依賴風險。這些調整需要營運投資和重新談判供應商契約，導致過渡期內出現短期庫存和物流方面的挑戰，進而影響前置作業時間和採購計畫。

基於全面細分的觀點能夠揭示臨床、材料、流程和通路等方面的具體促進因素，從而釋放客製化的商業化策略。

透過結構化細分分析複合疝氣修補術市場格局，可以深入了解臨床需求與商業性機會的交會點。在考慮最終使用者時，門診手術中心和醫院之間存在著截然不同的需求路徑。獨立門診中心和醫院附屬門診中心優先考慮的是手術量、器械易用性和門診病人康復指標，而私立和公立醫院則優先考慮的是手術覆蓋範圍廣、長期療效數據以及與醫院處方集相符的合約條款。這種差異對銷售策略、培訓計畫和庫存模式都具有重要意義。

深入的區域分析，重點關注全球醫療保健市場的監管差異、報銷複雜性和客製化商業化方法。

區域趨勢將對複合疝氣修補片的推廣路徑、監管反應和商業性實施產生重大影響。根據當地實際情況調整產品設計和市場推廣策略是製定有效策略的關鍵。在美洲，公立和私立醫療機構的醫療保健體系差異顯著，先進的外科手術主要集中在大型醫療中心。這使得實證醫學研究和支持微創手術的外科醫生培訓計畫成為優先事項。該地區的醫保報銷機制和醫院採購委員會強調併發症和再入院率的顯著降低。

策略競爭格局分析表明，材料創新、證據產生和供應鏈韌性如何驅動差異化和商業性優勢。

在複合疝氣修補片領域，各公司之間的競爭體現出不同的策略策略，領導企業透過研發投入、製造地和臨床證據累積來脫穎而出。專注於材料創新的公司致力於改進塗層技術和聚合物配方，以期在防止粘連和促進組織整合方面獲得更顯著的臨床優勢；而強調系統級解決方案的公司則將輸送裝置、固定輔助工具和外科醫生培訓相結合，構建能夠縮短手術時間並降低併發症風險的價值提案。

為製造商和醫療服務提供者提供切實可行、影響深遠的策略行動，以加速臨床應用、降低價值鏈風險並展現手術價值。

產業領導者可以採取多項切實可行的措施，貫穿複合疝氣修補片價值鏈，以鞏固市場地位、推動產品普及並管控風險。首先，將產品設計與手術流程相匹配——尤其是在最佳化腹腔鏡輸送系統的同時，保持對開放性手術技術的通用性——可以減輕外科醫生的負擔並擴大適用範圍。投資外科醫生培訓和指導，可以幫助製造商縮短學習曲線，並在不同的臨床環境中驗證治療效果的一致性。

該研究透過結合專家訪談、臨床文獻綜合和供應鏈分析的穩健的多方法研究設計，檢驗了其研究結果和建議。

本執行摘要的研究採用了多方法研究模式，整合了定性和定量數據，以確保研究結果的可靠性、檢驗和與相關人員的相關性。主要研究包括對各類相關人員進行結構化訪談，這些利害關係人包括精通腹腔鏡和開放性手術的外科醫生、醫院採購人員、分銷公司高階主管和監管專家。這些訪談深入了解了手術技術偏好、證據期望和分銷管道機制。

整合臨床、技術和商業性的必要因素，以支持創新、證據和營運執行的策略協調，從而實現持續應用。

本執行摘要了目前影響複合疝氣修補片市場的臨床需求、材料創新、監管趨勢和商業性因素之間的相互作用。關鍵主題包括：微創治療的持續發展、兼具減少沾黏和組織整合功能的先進複合材料和塗層的湧現，以及在政策主導的成本壓力下對穩健供應鏈的需求。這些趨勢正在影響製造商和分銷商的產品設計、證據優先順序和市場推廣模式。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 複合疝氣修補片市場（依材料類型分類）

  • ePTFE複合材料
  • 聚丙烯複合材料

9. 複合疝氣修補片市場（治療方法分類）

  • 腹腔鏡修補術
    • TAPP
    • TEP
  • 開放性手術

第10章 依最終用戶分類的複合疝氣修補片市場

  • 門診手術中心
  • 醫院
    • 私立醫院
    • 公立醫院

第11章 複合疝氣修補片市場（按應用領域分類）

  • 切口疝
    • 第一切口疝
    • 復發性切口疝
  • 腹股溝疝氣
  • 腹壁疝
    • 上腹部
    • 臍部

第12章 複合疝氣修補片市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 複合疝氣修補片市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國複合疝氣修補片市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

15. 美國複合疝氣修補片市場

第16章：中國複合疝氣修補片市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Aesculap AG
  • Atrium Medical Corporation
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • CR Bard, Inc.
  • Coloplast A/S
  • CONMED Corporation
  • Cook Medical Incorporated
  • Cousin Biotech
  • Dipromed SRL
  • FEG Textiltechnik mbH
  • Getinge AB
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Lifecell Corporation
  • Lohmann & Rauscher GmbH & Co. KG
  • Medtronic plc
  • Smith & Nephew plc
  • Tela Bio, Inc.
  • Teleflex Incorporated
  • Tepha, Inc.
  • WL Gore & Associates, Inc.
Product Code: MRR-7B550E008DB0

The Composite Hernia Patch Market was valued at USD 1.14 billion in 2025 and is projected to grow to USD 1.19 billion in 2026, with a CAGR of 6.11%, reaching USD 1.72 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.14 billion
Estimated Year [2026] USD 1.19 billion
Forecast Year [2032] USD 1.72 billion
CAGR (%) 6.11%

Foundational overview of composite hernia patch clinical rationale, regulatory signals, and stakeholder priorities that shape adoption pathways and product development

Composite hernia patches have become pivotal tools in modern hernia repair, combining engineered substrates and barrier technologies to balance tissue integration with reduced adhesion risk. This introduction frames the clinical rationale, core product attributes, and stakeholder considerations that define current adoption dynamics, while setting the tone for deeper analysis. Clinicians evaluate composite constructs primarily on biocompatibility, handling characteristics, fixation requirements, and long-term patient outcomes, and these clinical priorities shape procurement and product development decisions.

From a commercial perspective, payers and providers increasingly demand evidence of comparative performance, procedural efficiency, and cost-effectiveness. Concurrently, regulatory authorities emphasize safety data and post-market surveillance, prompting manufacturers to invest in real-world evidence and iterative design improvements. Patient demographics and rising demand for outpatient procedures further influence packaging and sterilization formats, as well as surgeon training programs that ease the transition between open and minimally invasive techniques.

Taken together, the clinical, regulatory, and operational drivers establish a foundation for strategic positioning. As stakeholders seek devices that reconcile ease of use with consistent clinical outcomes, the composite hernia patch occupies a critical intersection of material science and surgical workflow optimization. This introduction prepares readers for a structured examination of market dynamics, segmentation nuances, and strategic implications that follow.

Critical evolution in surgical technique preferences, material innovations, and procurement pressures that are redefining product design and adoption dynamics

Over recent years, multiple transformative shifts have redefined how composite hernia patches are developed, adopted, and reimbursed, and understanding these shifts is essential for strategic planning. First, the move toward minimally invasive procedures and same-day surgical workflows has elevated the importance of meshes optimized for laparoscopic handling, rapid deployment, and secure fixation, thereby influencing product design choices and training investments. As a result, manufacturers are prioritizing low-profile constructs and delivery systems that reduce operative time and simplify suturing or tack-free fixation.

Second, material science advances-particularly in composite substrates and anti-adhesive coatings-have improved the balance between tissue integration on the visceral side and adhesion prevention on the peritoneal interface. This technological progress is accompanied by a heightened focus on biocompatible polymers and surface modifications that mitigate chronic inflammation and seroma formation. Consequently, differentiation increasingly rests on demonstrable clinical endpoints rather than labeling alone.

Third, supply chain resilience and regulatory vigilance have gained prominence, prompting diversified sourcing and enhanced quality controls. Moreover, payer scrutiny and value-based procurement models are driving demands for longitudinal evidence and bundled care paradigms that reward reduced complications and readmissions. Together, these shifts are reshaping commercial strategies, clinical adoption patterns, and R&D priorities across the ecosystem.

How tariff-driven supply chain reconfiguration, sourcing diversification, and procurement scrutiny reshaped cost management and commercial engagement in 2025

The policy environment introduced by the United States tariffs in 2025 has generated meaningful implications across supply chains, sourcing strategies, and price optimization efforts for composite hernia patch stakeholders. In response to tariff-driven cost pressures, manufacturers and distributors reassessed sourcing, favoring nearshoring and diversified supplier portfolios to mitigate single-origin exposure. These adjustments required operational investments and renegotiation of supplier contracts, and the transition periods produced short-term inventory and logistics challenges that affected lead times and procurement planning.

Consequently, health systems and ambulatory surgical centers adopted more rigorous procurement frameworks to manage total landed costs, including duties, freight, and inventory holding. This shift led some buyers to prioritize suppliers with vertically integrated manufacturing or local production capabilities to stabilize supply and reduce tariff vulnerability. At the same time, the additional cost pressure accelerated cost-containment discussions with clinical teams and devices committees, emphasizing the need to demonstrate procedure-level value and complication reduction.

In parallel, tariff-induced pricing volatility intensified the focus on distributor relationships versus direct sales channels, with organizations reassessing contractual terms to preserve margin and service levels. Taken together, the tariff environment catalyzed strategic realignment across sourcing, pricing, and commercial engagement models that will influence procurement decisions and competitive positioning.

Comprehensive segmentation-driven perspective revealing clinical, material, procedural, and channel-specific drivers that unlock tailored commercialization strategies

Analyzing the composite hernia patch landscape through structured segmentation reveals actionable insights about where clinical demand converges with commercial opportunity. When end users are considered, ambulatory surgical centers and hospitals present distinct pathways; ambulatory centers, both freestanding and hospital-affiliated, emphasize throughput, device ease of use, and outpatient recovery metrics, while private and public hospitals prioritize broad procedural coverage, long-term outcome data, and contract terms that align with institutional formularies. This contrast informs sales strategies, training programs, and inventory models.

Approach-based segmentation further distinguishes product requirements, as laparoscopic repair modalities such as TAPP and TEP necessitate low-profile profiles and delivery systems suited to insufflation and minimal port manipulation, whereas open repair techniques like Lichtenstein repair and mesh plug technique place a premium on handling characteristics, fixation options, and soft-tissue conformity. These clinical preferences drive design trade-offs for manufacturers balancing versatility against procedure-specific optimization.

Material type segmentation highlights the role of ePTFE composite and polypropylene composite constructs, each offered with or without anti-adhesive coating, and decisions between these options are influenced by surgeon experience, adhesion risk profiles, and institutional preferences for long-term tissue integration. Application-based segmentation-covering incisional hernia, inguinal hernia, and ventral hernia with further granularity into primary versus recurrent incisional and epigastric versus umbilical ventral types-reveals how clinical complexity and recurrence risk affect device selection and evidence requirements. Finally, sales channel segmentation differentiates direct sales from distributor networks, with distributor operations further divided into international and local distributors, and each channel imposes different service expectations, contracting structures, and regional market access dynamics. Together, these layered segments inform targeted development, go-to-market planning, and post-sale support models.

Detailed regional analysis emphasizing regulatory diversity, reimbursement complexity, and tailored commercialization approaches across global healthcare markets

Regional dynamics exert a powerful influence on adoption pathways, regulatory navigation, and commercial execution for composite hernia patches, and an effective strategy must align product design and go-to-market tactics with regional realities. In the Americas, healthcare systems vary widely between public and private payers, and there is significant concentration of advanced surgical adoption in high-volume centers, which prioritizes evidence generation and surgeon education programs to support minimally invasive approaches. Reimbursement frameworks and hospital procurement committees in this region favor demonstrable reductions in complications and readmissions.

Across Europe, the Middle East & Africa, regulatory conformity and reimbursement heterogeneity create a mosaic of opportunities and barriers; centralized approvals coexist with country-level coverage decisions, and pricing pressures in many markets require compelling health-economic narratives. In contrast, the Middle East and parts of Africa present pockets of rapid infrastructure investment where suppliers can partner with local providers to introduce advanced procedural training and supply-chain solutions. Transitioning eastward, the Asia-Pacific region demonstrates wide divergence between mature markets with advanced hospital systems and emerging markets with growing surgical capacity; local manufacturing and strategic distributor partnerships are often critical to scaling access, while culturally specific procurement practices and surgeon preferences influence adoption speed.

Taken together, regional insights underscore the importance of flexible commercial models, localized evidence initiatives, and investments in surgeon training and supply continuity to support sustained growth across diverse healthcare environments.

Strategic competitive landscape analysis showing how material innovation, evidence generation, and supply chain resilience drive differentiation and commercial advantage

Competitive dynamics among companies operating in the composite hernia patch space reflect varied strategic postures, with leaders differentiating through R&D investments, manufacturing footprint, and evidence generation. Firms focusing on material innovation pursue incremental improvements in coating technologies and polymer formulations, seeking to deliver clearer clinical advantages in adhesion prevention and tissue integration. Others emphasize systems-level solutions, bundling delivery devices, fixation adjuncts, and surgeon training to create value propositions that reduce operative time and complication risk.

Strategic partnerships, selective licensing, and targeted acquisitions have emerged as common tactics to accelerate time-to-market for novel materials and to secure distribution in key geographies. Moreover, companies that invest in post-market surveillance and registries strengthen customer trust by demonstrating long-term safety profiles, which becomes increasingly important as procurement committees demand outcomes-based evidence. Operational excellence in quality systems and supply chain redundancy is another differentiator, particularly for organizations that serve high-volume ambulatory centers where reliable delivery and consistent device performance are paramount.

Looking ahead, competitive advantage will accrue to companies that combine robust clinical data with scalable manufacturing, flexible commercialization channels, and programs that support surgeon adoption. Those who align product innovation with demonstrable procedural benefits and institutional cost priorities will be best positioned to influence purchasing decisions and clinical guidelines.

Practical, high-impact strategic actions for manufacturers and providers to accelerate clinical adoption, reduce supply chain exposure, and demonstrate procedural value

Industry leaders can pursue several pragmatic actions to strengthen market position, accelerate adoption, and manage risk across the composite hernia patch value chain. First, aligning product design with procedural workflows-specifically optimizing for laparoscopic delivery systems while maintaining versatility for open techniques-reduces friction for surgeons and broadens addressable use cases. By investing in surgeon training and proctoring, manufacturers can shorten learning curves and demonstrate consistent outcomes across care settings.

Second, diversifying supply chains and establishing regional manufacturing capabilities or preferred local partners mitigates tariff and logistics exposure while improving responsiveness to demand fluctuations. In parallel, investing in robust post-market data collection, registries, and real-world evidence projects supports reimbursement discussions and bolsters procurement negotiations; these initiatives should emphasize clinically relevant endpoints such as complication reduction and patient recovery metrics.

Third, companies should tailor commercial models by region and by provider type, integrating direct sales in high-touch accounts and selective distributor partnerships in markets where scale and local relationships are essential. Finally, adopting value-based contracting pilots with leading health systems can demonstrate total-cost-of-care improvements and build the business case for broader adoption. Taken together, these steps offer a cohesive roadmap for maintaining competitiveness and delivering measurable clinical and economic value.

Robust multi-method research design combining expert interviews, clinical literature synthesis, and supply chain analysis to validate findings and recommendations

The research underpinning this executive summary synthesized qualitative and quantitative inputs through a multi-method approach designed to ensure reliability, triangulation, and relevance to stakeholders. Primary research included structured interviews with a cross-section of stakeholders, encompassing surgeons experienced in laparoscopic and open techniques, hospital procurement leaders, distributor executives, and regulatory specialists. These conversations informed an understanding of procedural preferences, evidence expectations, and channel mechanics.

Secondary research involved a systematic review of peer-reviewed clinical literature, regulatory filings, and device labeling to characterize material properties, safety signals, and procedural outcomes. Data triangulation integrated supply chain intelligence and policy developments to assess impacts on sourcing and pricing dynamics. Throughout the process, findings were validated via expert panels and clinical advisors who reviewed key assumptions and identified potential blind spots.

Finally, methodological safeguards such as source corroboration, conflict-of-interest screening, and iterative revision cycles were employed to enhance objectivity. This rigorous approach supports confidence in the thematic conclusions and strategic recommendations presented here, while also enabling customization for client-specific scenarios and supplementary analyses where deeper granularity is required.

Synthesis of clinical, technological, and commercial imperatives underscoring strategic alignment between innovation, evidence, and operational execution for durable adoption

This executive summary distilled the interplay of clinical needs, material innovation, regulatory dynamics, and commercial forces that currently shape the composite hernia patch landscape. Key themes include the persistent shift toward minimally invasive care pathways, the emergence of advanced composite materials and coatings that reconcile integration with reduced adhesions, and the imperative for resilient supply chains in the face of policy-driven cost pressures. These converging trends influence product design, evidence-generation priorities, and go-to-market models for manufacturers and distributors alike.

Importantly, segmentation and regional analyses reveal that success requires tailored strategies: devices optimized for laparoscopic deployment excel in ambulatory settings, whereas hospitals place heavier weight on longitudinal outcomes and contracting flexibility. Competitive advantage accrues to organizations that pair compelling clinical evidence with operational reliability and localized commercialization tactics. In short, stakeholders that align innovation with procedural utility and institutional value imperatives will be best positioned to capture clinical adoption and secure durable partnerships across care settings.

This conclusion underscores the need for integrated planning across R&D, regulatory, and commercial functions to translate technical improvements into measurable clinical and economic benefits within diverse healthcare environments.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Composite Hernia Patch Market, by Material Type

  • 8.1. ePTFE Composite
  • 8.2. Polypropylene Composite

9. Composite Hernia Patch Market, by Approach

  • 9.1. Laparoscopic Repair
    • 9.1.1. TAPP
    • 9.1.2. TEP
  • 9.2. Open Repair

10. Composite Hernia Patch Market, by End User

  • 10.1. Ambulatory Surgical Center
  • 10.2. Hospital
    • 10.2.1. Private Hospital
    • 10.2.2. Public Hospital

11. Composite Hernia Patch Market, by Application

  • 11.1. Incisional Hernia
    • 11.1.1. Primary Incisional
    • 11.1.2. Recurrent Incisional
  • 11.2. Inguinal Hernia
  • 11.3. Ventral Hernia
    • 11.3.1. Epigastric
    • 11.3.2. Umbilical

12. Composite Hernia Patch Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Composite Hernia Patch Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Composite Hernia Patch Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Composite Hernia Patch Market

16. China Composite Hernia Patch Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Aesculap AG
  • 17.6. Atrium Medical Corporation
  • 17.7. B. Braun Melsungen AG
  • 17.8. Baxter International Inc.
  • 17.9. Baxter International Inc.
  • 17.10. Becton, Dickinson and Company
  • 17.11. C. R. Bard, Inc.
  • 17.12. Coloplast A/S
  • 17.13. CONMED Corporation
  • 17.14. Cook Medical Incorporated
  • 17.15. Cousin Biotech
  • 17.16. Dipromed SRL
  • 17.17. FEG Textiltechnik mbH
  • 17.18. Getinge AB
  • 17.19. Integra LifeSciences Holdings Corporation
  • 17.20. Johnson & Johnson
  • 17.21. Lifecell Corporation
  • 17.22. Lohmann & Rauscher GmbH & Co. KG
  • 17.23. Medtronic plc
  • 17.24. Smith & Nephew plc
  • 17.25. Tela Bio, Inc.
  • 17.26. Teleflex Incorporated
  • 17.27. Tepha, Inc.
  • 17.28. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL COMPOSITE HERNIA PATCH MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL COMPOSITE HERNIA PATCH MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES COMPOSITE HERNIA PATCH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA COMPOSITE HERNIA PATCH MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY EPTFE COMPOSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY EPTFE COMPOSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY EPTFE COMPOSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY POLYPROPYLENE COMPOSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY POLYPROPYLENE COMPOSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY POLYPROPYLENE COMPOSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY TAPP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY TAPP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY TAPP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY TEP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY TEP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY TEP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY OPEN REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY OPEN REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY OPEN REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY PRIMARY INCISIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY PRIMARY INCISIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY PRIMARY INCISIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY RECURRENT INCISIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY RECURRENT INCISIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY RECURRENT INCISIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY INGUINAL HERNIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY INGUINAL HERNIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY INGUINAL HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY EPIGASTRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY EPIGASTRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY EPIGASTRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY UMBILICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY UMBILICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY UMBILICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS COMPOSITE HERNIA PATCH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 144. GCC COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GCC COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. GCC COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 147. GCC COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 148. GCC COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. GCC COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 150. GCC COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. GCC COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 152. GCC COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 171. G7 COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. G7 COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. G7 COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 174. G7 COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 175. G7 COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. G7 COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 177. G7 COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. G7 COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 179. G7 COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 180. NATO COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. NATO COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. NATO COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 183. NATO COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 184. NATO COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. NATO COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 186. NATO COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. NATO COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 188. NATO COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES COMPOSITE HERNIA PATCH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA COMPOSITE HERNIA PATCH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)